Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors

Author： de Gaetano G.   Donati M.B.   Cerletti C.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.24, Iss.5, 2003-05, pp. : 245-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclooxygenase-1/2 (COX-1/COX-2) and 5-lipoxygenase (5-LOX) inhibitors of the 6,7-diaryl-2,3-1H-dihydropyrrolizine type

By Ulbrich H.   Fiebich B.   Dannhardt G.  

European Journal of Medicinal Chemistry, Vol. 37, Iss. 12, 2002-12 ,pp. : 953-959

Elsevier

Access to resources Recommend Favorite

Recent Development in the Field of Dual COX / 5-LOX Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 6, 2004-08 ,pp. : 633-638

Bentham Science Publishers

Access to resources Recommend Favorite

COX inhibitors for airway inflammation

By Malhotra Sanjay   Deshmukh Sangram Shesharao   Dastidar Sunanda Ghosh  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 2, 2012-02 ,pp. : 195-207

Informa Healthcare

Access to resources Recommend Favorite

COX-2 selective inhibitors: analysis of the renal effects

By Perazella Mark A  

Expert Opinion on Drug Safety, Vol. 1, Iss. 1, 2002-05 ,pp. : 53-64

Informa Healthcare

Access to resources Recommend Favorite

Gastrointestinal Safety of Selective COX-2 Inhibitors

By  

Current Pharmaceutical Design, Vol. 8, Iss. 12, 2002-06 ,pp. : 1077-1089

Bentham Science Publishers

Access to resources Recommend Favorite